Quarterly report · Q2
4452.TEDINET S100RNNK
Period2023-01-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥738.5bn | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥390.7bn | 2023-04-01 → 2023-06-30d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.55T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥733.9bn | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥387.1bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥25.9bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥18.6bn | 2023-04-01 → 2023-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥53.7bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥30.7bn | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥28.6bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥20.2bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥115.8bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥60.5bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥34.8bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥16.6bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥11.8bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥86.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥38.9bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥20.6bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥17.7bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥12.4bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥39.8bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥21.0bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥1.74T | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥1.73T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.76T | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥713.2bn | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥731.0bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.03T | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥995.4bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.04T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥983.9bn | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.00T | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥972.1bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.02T | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥275.7bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥268.2bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥280.5bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥336.1bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥62.4bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥130.9bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥27.7bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥33.4bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥74.9bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥40.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥34.4bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥139.3bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥67.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥35.76 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥25.4 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥183.28 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥82.17 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥43.67 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥35.76 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥25.4 | 2023-04-01 → 2023-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥183.27 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥82.16 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥43.67 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 57.5% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.3% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 57.7% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | ¥555m |
| jpcrp040300-q2r_E00883-000Chemical Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥11.1bn |
| jpcrp040300-q2r_E00883-000Consumer Products Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥14.3bn |
| jpcrp040300-q2r_E00883-000Cosmetics Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥2.5bn |
| jpcrp040300-q2r_E00883-000Health And Beauty Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E00883-000Hygiene And Living Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E00883-000Life Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥1.1bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥25.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | ¥196m |
| jpcrp040300-q2r_E00883-000Chemical Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥20.1bn |
| jpcrp040300-q2r_E00883-000Consumer Products Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥33.3bn |
| jpcrp040300-q2r_E00883-000Cosmetics Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥2.2bn |
| jpcrp040300-q2r_E00883-000Health And Beauty Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥18.2bn |
| jpcrp040300-q2r_E00883-000Hygiene And Living Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥13.1bn |
| jpcrp040300-q2r_E00883-000Life Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥104m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥53.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 873
| Item | Context | Value | Unit |
|---|---|---|---|
| Payments for purchase of treasury shares fin cf IFRS | Prior1YTDDuration | -22583000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | CurrentYTDDuration | -8000000 | JPY |
| Dividends paid fin cf IFRS | Prior1YTDDuration | -34148000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYTDDuration | -34434000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | Prior1YTDDuration | -207000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | CurrentYTDDuration | -923000000 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | 2048000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | 2214000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | -67238000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -34374000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | Prior1YTDDuration | -79543000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | CurrentYTDDuration | -5414000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 336069000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 268248000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 24001000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 12826000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 280527000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 275660000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 238335000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 176751000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000LifeCareBusinessReportableSegmentMember | 25804000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000CosmeticsBusinessReportableSegmentMember | 115989000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 556879000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ChemicalBusinessReportableSegmentMember | 177022000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_ReportableSegmentsMember | 733901000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Sales to external customers IFRS | Prior1YTDDuration | 733901000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000LifeCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000CosmeticsBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ConsumerProductsBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ChemicalBusinessReportableSegmentMember | 22090000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_ReportableSegmentsMember | 22090000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_ReconcilingItemsMember | -22090000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration | - | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 238335000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 176751000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000LifeCareBusinessReportableSegmentMember | 25804000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000CosmeticsBusinessReportableSegmentMember | 115989000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 556879000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ChemicalBusinessReportableSegmentMember | 199112000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_ReportableSegmentsMember | 755991000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_ReconcilingItemsMember | -22090000000 | JPY |
| Net sales IFRS | Prior1YTDDuration | 733901000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 13066000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 18204000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000LifeCareBusinessReportableSegmentMember | -104000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000CosmeticsBusinessReportableSegmentMember | 2183000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 33349000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |